Pharmacom Labs | OZEMOS (Semaglutide / Ozempic) | 2025-04 | Janoshik

[RThoads]

OZEMOS: Semaglutide (Ozempic) from Pharmacom Labs

Analytic testing performed by Janoshik.

RESULTS:

1. Qualitative analysis: the sample contains the active ingredient Semaglutide.
2. Quantitative analysis showed the content of active ingredient: 1.97 mg.
3. Quantitative analysis showed the purity of the active ingredient: 98.493%

Analysis conducted: 14 April 2025